The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells.
Red blood cells (RBCs) can be used for vascular delivery of encapsulated or surface-bound drugs and carriers. Coupling to RBC prolongs circulation of nanoparticles (NP, 200 nm spheres, a conventional model of polymeric drug delivery carrier) enabling their transfer to the pulmonary vasculature witho...
Main Authors: | Daniel Pan, Omayra Vargas-Morales, Blaine Zern, Aaron C Anselmo, Vivek Gupta, Michael Zakrewsky, Samir Mitragotri, Vladimir Muzykantov |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4803339?pdf=render |
Similar Items
-
Nanoparticles in the clinic: An update
by: Aaron C. Anselmo, et al.
Published: (2019-09-01) -
Nanoparticles in the clinic: An update post COVID‐19 vaccines
by: Aaron C. Anselmo, et al.
Published: (2021-09-01) -
Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics
by: Patrick M. Glassman, et al.
Published: (2020-05-01) -
Formulation of biocompatible polymeric nanoparticles as therapeutic carriers in inhaled drug delivery : effects of different formulation parameters.
by: Shi, Fiona Xuehui.
Published: (2009) -
BioTM Buzz (Volume 5, Issue 3): The Future is Bright
by: Samir Mitragotri, et al.
Published: (2020-09-01)